Pharmafile Logo
Pharmafocus logo
Advanced Search

Novo Nordisk

Showing 12 posts of 177 posts found.

Novo expands diabetes research in China

September 16, 2010
Research and Development China, Novo Nordisk, diabetes

Diabetes is at the core of Novo Nordisk’s latest investment in China, where the company plans to more than double …

News
Novo Nordisk's Victoza

Low dose Victoza on track for NICE approval

September 10, 2010
Sales and Marketing NICE, Novo Nordisk, Victoza

Novo Nordisk is on track to receive NICE approval for its type II diabetes drug Victoza, but will still have …

News

Victoza lifts Novo Nordisk

August 9, 2010
Sales and Marketing 2010 financials, Novo Nordisk, Q2

Novo Nordisk has posted a set of healthy results following strong sales from its insulin range and newly launched diabetes …

News

Novo agrees price cut deal with Greece

June 16, 2010
Sales and Marketing Greece, Novo Nordisk, insulin, pricing

Novo Nordisk has agreed to resume supply of its insulins to the Greek market after pulling them last month as …

News
Novo ethics tools

Digital Pharma: Novo Nordisk’s online ethics tools

June 8, 2010
Medical Communications, Sales and Marketing Novo Nordisk, compliance, ethics

Two new e-learning tools have been launched to help shed some light on ethical grey areas and give individuals a …

News

Victoza claims head-to-head victory over Januvia

April 29, 2010
Research and Development, Sales and Marketing Novo, Novo Nordisk, Victoza

Novo Nordisk says its diabetes treatment showed “significant” benefits over Merck’s rival Januvia in a head-to-head trial. Results published in …

News
Victoza pack

Novo to challenge NICE Victoza guidance

February 15, 2010
Sales and Marketing NICE, Novo Nordisk, Victoza

NICE has given a partial green light to Novo Nordisk’s type II diabetes treatment Victoza, backing its use as part …

News

Novo buoyed by insulin portfolio

February 2, 2010
Sales and Marketing 2009 financials, Novo Nordisk, Victoza

Danish pharma company Novo Nordisk managed a double-digit rise in sales and profits in 2009, buoyed by insulin products NovoRapid, …

News
Novo Nordisk HQ

Pancreatitis concerns take shine off Victoza approval

January 28, 2010
Sales and Marketing GLP-1, Novo Nordisk, Victoza

The FDA has approved Novo Nordisk’s Victoza a new once-daily injection for patients with type II diabetes. The drug will …

News

Victoza pill trial begins

January 19, 2010
Research and Development, Sales and Marketing GLP-1, Novo Nordisk, Victoza, diabetes, type II

A promising new diabetes treatment which can be taken as a pill instead of as an injection has just begun …

News

Novo Nordisk plans summer launches for new diabetes drug

May 7, 2009
Research and Development, Sales and Marketing Novo Nordisk, Victoza, diabetes

Novo Nordisk is preparing Victoza for a summer launch into its first European markets, including the UK, after it was …

News

Working Life: Viggo Birch

November 10, 2008
Business Services, Research and Development, Sales and Marketing Novo Nordisk, WL, careers

How did you arrive at your current position?A long story. I started in Mobil Oil in Denmark after graduating from …

Feature

Latest content

GSK shares data from global shingles survey

December 1, 2023

AbbVie to acquire ImmunoGen for approximately $10.1bn

December 1, 2023

FDA accepts NDA for Karuna’s schizophrenia treatment

November 30, 2023

Vivos Therapeutics gains FDA 510(k) clearance for sleep apnea treatment device

November 30, 2023

Tolremo doses first patient in phase 1 trial for drug to combat transcriptional cancer drug resistance

November 29, 2023